pre-seed
Stage
1
Investors
About
Nephrogen is a biotech company developing an AI-driven platform that designs and validates novel adeno-associated virus delivery vehicles for gene therapies targeting kidney and pancreatic diseases.
Explore Nephrogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.